Tag: CV Sciences

StaffDecember 12, 2023
Daily-Hit-Header.png

6min00
The Daily Hit is a recap of the top financial news stories for Dec. 12, 2023. On the Site Michigan Man Who Sued NY Over Cannabis Licensing Goes After Washington State A Michigan cannabis entrepreneur on a quest to remove residency requirements from adult-use cannabis programs continues to stay busy in state courts. Kenneth Gay, […]

StaffMarch 29, 2023
daily-hit.jpg

4min00
The Daily Hit is a recap of the top financial news stories for March 29, 2023. On the Site Columbia Care Sales Fall in Fourth Quarter as Company Exits Markets Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) saw its net loss for the fourth quarter ballooned to an eye-popping $300 million, compared with […]

StaffNovember 15, 2021
CV.jpg

3min00
CV Sciences, Inc. (OTCQB:CVSI) announced its financial results for the quarter ended September 30, 2021, with revenue falling 8% to $5.1 million for the third quarter of 2021 versus $5.6 million for the third quarter of 2020. CV Sciences said that sales were hurt by increased market competition, which was largely due to the uncertain […]

Debra BorchardtMarch 16, 2020
CVSI.png

4min00
Hemp CBD company CV Sciences, Inc. (OTCQB:CVSI)  announced its financial results for the year ended December 31, 2019, with total revenue of $53.7 million for the fiscal year 2019. During the fourth quarter of 2019, sales declined 34% to $9.4 million compared to $14.2 million in the prior-year period. The company blamed the decline on […]

William SumnerAugust 7, 2019
daily_hit004-1280x533.png

6min00
It’s time for your Daily Hit of cannabis financial news for August 7, 2019. On the Site LeafLink Online cannabis wholesale marketplace, LeafLink announced the completion of a $35M Series B round of funding. The round was led by Thrive Capital. Current investors Nosara Capital, Lerer Hippeau, Wisdom VC, and Thought Into Action Ventures also […]

StaffAugust 6, 2019
daily_hit004-1280x533.png

8min00
It’s time for your Daily Hit of cannabis financial news for August 6, 2019. On The Site GW Pharmaceuticals British biotech firm GW Pharmaceuticals pls (NASDAQ: GWPH) second-quarter net sales of $68.4 million of the company’s cannabis-related drug Epidiolex, which is prescribed for children with rare epilepsy diseases. For the first half of 2019, GW […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.